Rezolute, Inc. (RZLT)
1.63
-0.17
(-9.44%)
USD |
NASDAQ |
Dec 15, 16:00
1.67
+0.04
(+2.45%)
After-Hours: 04:19
Rezolute Research and Development Expense (TTM): 61.92M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Pfizer Inc. | 10.13B |
| Geron Corp. | 81.32M |
| XOMA Royalty Corp. | 2.295M |
| Sarepta Therapeutics, Inc. | 1.389B |
| Astria Therapeutics, Inc. | 98.04M |